Why should I, founder of a profitable and fast growing health tech company, allow you, a dusty fund manager, to receive equity and a board seat in my company
Happy tau day!
Today I'll take a break from my break from twittering and do another twitter AMA.
Feel free to ask questions about any crypto or non-crypto topic. People I follow can reply (to minimize spam), everyone can quote, I'll check both!
@victorforissier
Outsized returns come from companies who marry Moore’s law on their technology with creating business value. Important to recognize real value in a frothy market
"Why is there stagnation with real technology and economic progress?"
There have been no big breakthroughs recently, and for the first time in centuries, the younger generation has lower economic expectations than their parents.
At CAPDM’s Annual Conference,
@CathyTie
Will share insight on “Opportunities For Traditional Pharmaceutical Supply Chain Companies To Capitalize On Direct-To-Consumer Telehealth Trends”
#CAPDM
#CapdmAnnualConference
Wrote a piece about the devastating last two months in China, where a single pack of Paxlovid is selling for over $7,000 USD (and we get it for free in North America). Over 70% of China's 1.4 billion population got Covid since the lockdown measures stopped in early December.
"The solution to biotech is not accelerating research even faster, it’s just stopping it altogether."
"The zeitgeist went from transhumanism pre-2015 to luddite."
"Perhaps the existential risk isn't science and technology (eg AI and CRISPR), but a one world totalitarian state."
@grstaikos
It's also an easy sell to undergrads and grad students that creating SaaS tools with high valuation multiples and nice Meta/Google offices is easier to make money through than academia and doing deep tech that actually matter. Incentives and systems all wrong.